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The goal of this project is to characterize a new mouse model of alcohol-
enhanced acute lung injury (ALI) and to determine the role of plasminogen 
activator inhibitor-1 (PAI-1) in this model.  Male mice (WT and PAI-1-/-) were 
exposed to ethanol-containing Lieber-DeCarli diet or pair-fed control diet for 6 
weeks; some animals were administered intraperitoneal lipopolysaccharide (LPS) 
prior to sacrifice. Chronic alcohol feeding enhanced induction of the chemokines 
MIP-2 and KC (murine IL-8 homologues) after LPS injection in wild type animals. 
This enhanced chemokine expression did not correlate with enhanced pulmonary 
neutrophil infiltration, however animals exposed to chronic ethanol showed 
sustained alveolar septal thickening and enhanced 4-HNE staining, indicative of 
inflammatory damage. Septal thickening was completely attenuated in PAI-1-/- 
animals.  This work has developed a new mouse model which can be used to 
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elucidate the mechanisms of alcohol-enhanced ALI. A potential role of PAI-1 in 











ABSTRACT ....................................................................................................... vi 




INTRODUCTION ............................................................................................... 1 
MATERIALS AND METHODS ........................................................................... 5 
Animals and treatments……………………………………………………….. 5 
Chronic model of alcohol exposure ........................................................... 5 
Clinical Chemistry ...................................................................................... 8 
Histology .................................................................................................... 8 
General morphology ............................................................................... 8 
Scoring of septal thickening and alveolar hemorrhage ........................... 8 
Neutrophil accumulation ......................................................................... 9 
            Immunohistochemistry ........................................................................... 9 
Myeloperoxidase activity…………………………………………………........ 11 
RNA isolation and real-time RT-PCR………………………………………… 11 
Statistical analysis……………………………………………………………… 12 
RESULTS .......................................................................................................... 14 
DISCUSSION .................................................................................................... 27 
SUMMARY AND CONCLUSIONS .................................................................... 32 
ix 
 
Strengths of this work .......................................................................... 32 
Unanswered questions and future directions ....................................... 34 
Conclusions ......................................................................................... 37 
REFERENCES .................................................................................................. 38 
APPENDIX ........................................................................................................ 45 







LIST OF FIGURES 
FIGURE PAGE 
1. Lieber-Decarli model of chronic alcohol exposure ........................................ 7 
2. Table of routine parameters ......................................................................... 15 
3. Effect of chronic alcohol on pulmonary injury ............................................... 17 
4. Effect of chronic alcohol on indices of histological damage ......................... 18 
5. Effect of chronic alcohol on inflammatory cell recruitment ........................... 20 
6. Effect of chronic alcohol on MPO activity and F4/80 expression .................. 21 
7. Effect of chronic alcohol on expression of inflammatory mediators .............. 23 
8. Effect of chronic alcohol on pulmonary oxidative stress ............................... 24 
9. Effect of PAI-1 deletion on alcohol-enhanced pulmonary damage ............... 26 







Alcohol consumption is a common custom worldwide. In the United States 
alone, 87.6% of adults report consuming alcohol at some point in their lives (1). 
Moreover, over 17 million Americans have been diagnosed with an alcohol use 
disorder (1). This widespread consumption of alcohol continues despite the fact 
that the detrimental health effects of alcohol abuse are well-established. In fact, 
alcohol is known to contribute to the development of over 200 disease states (2), 
making alcohol the fifth leading risk factor for premature death and disability 
worldwide (3). The medical expenses for alcohol-related disease, combined with a 
loss in productivity, are estimated to cost the U.S. government around 223.5 billion 
dollars annually (4). Outside of lifestyle modification and treatment of secondary 
sequelae (e.g., decompensation in liver disease), treatment options to halt or 
reverse alcohol-related organ damage are limited. Moreover, despite increased 
understanding of alcohol dependence, over 90% of alcoholics will relapse at least 
once over a four year treatment period (5), meaning that the treatment of 
alcoholism is not always a viable option for preventing the negative health effects 
associated with alcohol abuse; this makes treatment of alcohol-related 
pathophysiology a critical target for investigation. Therefore, there is an urgent 
need to determine the mechanisms leading to alcohol-related organ injury in order 
to identify new targets to prevent or reverse disease progression. 
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The lung is recognized as a target of chronic alcohol abuse, and alcohol-
related lung injury is estimated to account for tens of thousands of deaths in the 
United States each year (6). Although chronic alcohol consumption is not directly 
linked to the development of lung disease (i.e., as it is to liver disease) alcohol is 
a significant risk factor in the morbidity/mortality of lung damage from other causes. 
For example, acute respiratory distress syndrome (ARDS), the most severe form 
of acute lung injury (ALI), occurs 3.7 times more often in people meeting the 
diagnostic criteria for alcohol use disorders (7, 8). Furthermore, Moss and 
colleagues demonstrated that chronic alcoholics who developed ARDS showed in-
hospital mortality rates of 65%, whereas nonalcoholic patients had mortality rates 
of 36% (7-9).   The exact mechanisms by which alcohol mediates these effects on 
the lung are unknown, but experimental alcohol consumption has been associated 
with the up-regulation of pro-inflammatory cytokines (10-12), disruption of 
regulatory signaling pathways (13), activation of tissue remodeling (14, 15), and 
the induction of oxidative stress in rodent lungs (16). These factors contribute to 
the development of an “alcoholic lung” phenotype. This phenotype appears to 
enhance the host’s susceptibility to serious lung diseases, including ARDS, ALI 
following severe trauma (e.g. car accident, gun shot, etc.), and respiratory infection 
(e.g., pneumonia) (6).  Therefore, the primary goal of the current work is to 
investigate the mechanisms by which chronic alcohol sensitizes the lung to injury 
and inflammation. 
Intraperitoneal (i.p.) injection of bacterial lipopolysaccharide (LPS), or 
endotoxemia-induced lung injury, is a common animal model employed to study 
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ALI and ARDS (17, 18). Indeed, this model has been demonstrated to cause 
sequestration of neutrophils in the pulmonary vasculature and interstitium (19, 20). 
Furthermore, i.p. LPS administration has been demonstrated to cause pulmonary 
edema, diffuse alveolar damage, and induction of inflammatory cytokines and 
chemokines, such as IL-6 and MCP-1 (21). Systemic administration of LPS (versus 
intratracheal) is a particularly relevant model to investigate mechanisms of alcohol-
induced organ pathology. In fact, chronic alcohol consumption has been 
demonstrated to increase systemic LPS in patients (22), and this could in turn 
damage the lung. Furthermore, although intratracheal administration of LPS has 
been demonstrated to cause a large influx of PMNs into the alveoli, there are 
concerns that this model may include confounding factors, such as aspiration injury 
(20).  Others have demonstrated that chronic alcohol exposure enhances 
glutathione depletion and oxidative stress in a rat model of endotoxemia-induced 
ALI (16, 23). The effect of chronic alcohol exposure on endotoxemia-induced lung 
injury and inflammation in a mouse model has not been tested. The first goal of 
the current project is to characterize a mouse model of alcohol-enhanced acute 
lung injury. 
A major focus of the Arteel group’s recent research has been to investigate 
parallel and possibly interdependent mechanisms of liver and lung injury in the 
setting of chronic alcohol abuse. One proposed parallel mechanism of alcohol-
induced liver and lung injury is the induction of tissue remodeling. The activation 
of the coagulation cascade is a key response to acute injury which transiently alters 
the extracellular matrix (ECM). Plasminogen activator inhibitor-1, or PAI-1, is a key 
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regulator of the coagulation cascade. PAI-1 is an acute phase protein normally 
expressed by adipocytes and endothelial cells, but is also expressed by other cells 
during times of inflammation and/or stress (24). This group has identified a critical 
role of PAI-1 in the progression of alcohol-induced liver injury. Specifically, 
knocking out PAI-1 produced potent anti-inflammatory effects in a chronic enteral 
alcohol model (25). Similar effects have also been demonstrated in other models 
of hepatic inflammation, including LPS-induced liver injury enhanced by partial 
hepatectomy (26) or ethanol pre-exposure (27). PAI-1 is also known to contribute 
to the development of ALI and ARDS (28, 29), and elevated PAI-1 in 
bronchoalveolar lavage (BAL) fluid in patients with these conditions is associated 
with increased mortality (30-32). PAI-1 induction has also been demonstrated to 
enhance susceptibility to LPS-induced ALI in animal models (33). PAI-1 induction 
also enhances ALI in a model of bleomycin-induced lung injury (34). Although the 
role of PAI-1 has been studied in many models of lung injury, including cancer (35), 
fibrosis (36), and ALI (37), the role of PAI-1 in alcohol-enhanced ALI remains 
largely unknown. Therefore, the second goal of the current work is to determine if 







MATERIALS AND METHODS 
A. Animals and Treatments 
Mice were housed in a pathogen-free barrier facility accredited by the 
Association for Assessment and Accreditation of Laboratory Animal Care, and 
procedures were approved by the University of Louisville’s Institutional Animal 
Care and Use Committee. 
At time of sacrifice, animals were anesthetized with ketamine/xylazine (100/15 
mg/kg, i.p.).  Blood was collected from the vena cava just prior to sacrifice by 
exsanguination and citrated plasma was stored for further analysis.  Prior to lavage 
of the lungs, 10 mL of PBS was perfused through the heart to flush the pulmonary 
vasculature of erythrocytes.  Bronchoalveolar lavage (BAL) was performed by 
flushing the lung two times with 400 μL sterile PBS.  Cells in the BAL fluid (BALF) 
were separated by centrifugation and removed from remaining BALF and fixed on 
slides for further analysis (38).  Portions of lung tissue were snap-frozen in liquid 
nitrogen for later analysis or fixed in 10% neutral buffered formalin for subsequent 
sectioning and mounting on microscope slides  Total RNA was immediately 
extracted from fresh lung tissue using RNA-stat (Tel-Test, Austin, TX) and 
chloroform: phenol separation (see RNA isolation Methods). 
B. Chronic model of alcohol exposure 
Eight week old male C57BL6/J and PAI-1 knockout (B6.129S2-
Serpine1tm1Mlg/J: PAI-1−/−) mice were purchased from the Jackson Laboratory (Bar 
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Harbor, ME) and exposed to either ethanol-containing Lieber-DeCarli diet (Dyets, 
Inc.) or iso-caloric control diet.  During the exposure period, animals were housed 
in pairs in shoebox cages in a room held at 75 ˚F.  Diet was provided in vacuum 
tubes and replaced between 4 and 5 pm daily.  Both ethanol-fed animals and their 
pair-fed counterparts received control diet for the first two days of liquid diet feeding 
to allow acclimation to the liquid diet feeders.  After 2 days of acclimation, ethanol 
concentrations were increased incrementally over the course of three weeks 
before reaching the highest ethanol concentration, 6% (vol/vol) for the final three 
weeks of exposure.  Ethanol concentrations in the ethanol-containing diets were 
as follows: 0% for two days of acclimation, 1% for two days, 2% for two days, 4% 
for one week, 5% for one week, and 6% for three weeks.  Ethanol-containing diet 
was provided ad libitum for the entire course of the study.  Because of the relatively 
high caloric content of ethanol, pair-fed control animals received an iso-caloric 
control diet; the calories in the iso-caloric diet were matched by adding a calorie-
equivalent of maltose-dextrin.  To account for the reduced food consumption of 
ethanol-fed mice, pair-fed mice were given the volume of diet consumed by their 
ethanol-fed counterparts the night before.  At the conclusion of the feeding period, 
the two diet groups were further separated into additional groups that received 
either LPS (E. coli; 10 mg/kg i.p Sigma, St. Louis, MO) or vehicle (saline). Animals 







Figure 1: Lieber-DeCarli model of chronic alcohol exposure and 
experimental endotoxemia 
Mice received ethanol-containing or isocaloric maltose-dextrin containing Lieber-
DeCarli diet (see Materials and Methods) for six weeks and were injected with 
LPS (10 mg/kg i.p.) or vehicle (saline) 4 or 24 hours prior to sacrifice.  
6 Week EtOH Feeding






C. Clinical chemistry 
Plasma activity levels of alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) were determined spectrophotometrically using standard 
kits (Thermotrace, Melbourne, Australia). 
D. Histology 
1. General morphology 
Formalin fixed, paraffin embedded lung tissue was cut at 5 μm and mounted on 
charged glass slides.  Sections were deparaffinized with Citrisolv (Fisher, 
Waltham, MA) and rehydrated through graded ethanol.  Sections were then 
stained with hematoxylin and eosin (H&E).  After staining, samples were 
dehydrated through graded alcohol, washed in Citrisolv and then mounted with 
Permount (Fisher, Waltham, MA). 
2. Scoring of septal thickening and alveolar hemorrhage 
Twenty blinded photomicrographs per sample of hematoxylin and eosin-
stained paraffin embedded lung tissues were taken in successive fields at 400x 
magnification and saved. Four randomly selected alveolar septa per photograph 
were measured using the straight line tool on ImageJ software (39). Resulting 
measurements are given as length of the straight line pixels and represented as 
fold of control. As per guidelines established by the American Thoracic Society, 
areas of the tissue that were underinflated during histological preparation were 
avoided, as this may cause the septa to appear artificially thickened (17). 
Additionally, septa directly adjacent to a blood vessel or airway were avoided, as 
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these septa are normally thickened by collagen present in the peribronchovascular 
bundle (17). 
Alveolar hemorrhage was scored using twenty blinded photographs per 
sample of hematoxylin and eosin-stained paraffin embedded lung tissues taken at 
400x magnification. Each field was assessed for the presence of alveolar 
hemorrhage. Fields in which 0% of the tissue was hemorrhagic received a score 
of 0. Those with 1-25% hemorrhagic tissue received a score of 1, 26-50% received 
a score of 2, 51-75% received a score of 3, and 76-100% received a score of 4. 
The average score of 20 fields is reported. 
3. Neutrophil accumulation 
Neutrophil accumulation in lung tissue was measured using chloracetate 
esterase (CAE) staining. Briefly, formalin fixed, paraffin embedded lung tissue was 
cut at 5 μm and mounted on charged glass slides.  Sections were deparaffinized 
with Citrisolv (Fisher, Waltham, MA) and rehydrated through graded ethanol. 
Tissue specimens were incubated in a solution of napthol AS-D chloroacetate (1 
mg/ml) in N,N-dimethylformamide, with 4% sodium nitrite and 4% new fuchsin. The 
napthol AS-D chloroacetate is enzymatically hydrolyzed by chloroacetate esterase 
in neutrophils, liberating the napthol compound. Napthol combines with a freshly-
formed diazonium salt, leaving bright pink color deposits at the site of enzymatic 
activity (University of Calgary Airway Inflammation Research Group).   
4. Immunohistochemistry 
Immunohistochemical staining for markers of macrophages (F4/80) and 
oxidative stress (4-HNE) were performed as previously described (40). Briefly, 
10 
 
formalin-fixed, paraffin embedded sections (5 μm) were deparaffinized and 
rehydrated with graded ethanol solutions.  Endogenous peroxidase activity was 
quenched by incubating slides in a 3% H2O2 solution for 5 minutes at room 
temperature.   
For F4/80 staining, slides were incubated in an avidin-biotin blocking reagent 
(Dako, Carpinteria, CA) to reduce non-specific staining.   Then, slides were 
incubated in primary antibody for the F4/80 cell surface receptor (1:50 in 10% goat 
serum; Abcam, Cambridge MA) for two hours at room temperature.  The 
Vectastain Elite ABC kit was used for detection (Vector Laboratories, Inc., 
Burlingame, CA).  Briefly, tissue was incubated in a biotinylated anti-Rat IgG 
secondary antibody for 15 minutes at room temperature.  Tissue was then washed 
and incubated in a solution containing avidin-bound horseradish peroxidase (HRP) 
for 30 minutes.   
4-HNE staining was detected using the UltraVision Detection System (Thermo 
Scientific, Fremont, CA). Briefly, after hydrogen peroxide blocking, slides were 
incubated in Ultra V Blocking Solution to reduce non-specific stain. Then, slides 
were incubated in primary antibody for 4-HNE (1:500 in PBST+1% BSA, Alpha 
Diagnostics, San Antonio TX) for 30 minutes at room temperature. For detection, 
slides were incubated in biotinylated goat anti-Rabbit IgG secondary antibody for 
10 minutes at room temperature. Tissues were then washed and incubated in a 
solution containing avidin-bound horseradish peroxidase (HRP) for 10 minutes.   
The HRP substrate 3, 3’-diaminobenzidine (DAB) was added to tissue sections 
until positive (brown) staining was visible macroscopically.  Slides were 
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counterstained with Hematoxylin (Dako, Carpinteria, CA) for 1 minute, washed, 
dehydrated through graded ethanol and then mounted with Permount (Fisher, 
Waltham, MA).  Each slide contained a negative tissue section which does not 
receive primary antibody. 
E. Myeloperoxidase Activity 
Myeloperoxidase activity was measured as previously described (41, 42). 
Frozen lung tissue samples were thawed and homogenized in 50 mM potassium 
phosphate buffer (pH 6.0), then centrifuged at 9000 x g for 15 minutes at 4˚C. 
Supernatant (containing hemoglobin) was discarded, and the resulting pellet was 
resuspended in potassium phosphate buffer (pH 6.0) containing 50 mM 
hexadecyltrimethylammonium bromide (HTAB) and homogenized again. This 
suspension was sonicated, and snap frozen in liquid nitrogen and thawed for three 
freeze-thaw cycles. Samples were then centrifuged at 9000 x g for 10 minutes at 
4˚C. The resulting supernatant was then assayed spectrophotometrically for 
myeloperoxidase activity in 50 mM potassium phosphate (pH 6.) with 0.0005% 
hydrogen peroxide and 0.167 mg/mL o-dianisidine dihydrochloride (substrates of 
myeloperoxidase) at 450 nm. Results are reported as rate of reaction per mg of 
lung tissue. 
F. RNA Isolation and Quantitative Reverse-Transcription Polymerase Chain 
Reaction 
Total RNA was extracted from lung tissue by a guanidinium thiocyanate-based 
method (RNA STAT 60 Tel-Test, Ambion, Austin, TX). RNA concentrations were 
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determined spectrophotometrically and 1µg of total RNA was reverse transcribed 
using a kit (Quanta Biosciences, Gaithersburg MD). 
The pulmonary mRNA expression of select genes was detected by quantitative 
reverse-transcription polymerase chain reaction (qRT-PCR), which is routine for 
this group (27). PCR primers and probes for TNF-α, PAI-1, IL-6, and IL-1β were 
designed using Primer 3 (Whitehead Institute for Biomedical Research, Cambridge 
MA). Primers and probes for ICAM-1, VCAM-1, PECAM (CD31), MIP-2, KC, F4/80, 
MCP-1, MIP-1β, lungkine, and B-actin were purchased from Life Technologies. All 
primers were designed to cross introns and ensure that only cDNA and not 
genomic DNA was amplified. PerfeCta qPCR Fast Mix (Quanta Biosciences, 
Gaithersburg MD) was used to prepare the PCR mixture. This 2X mixture is 
optimized for TaqMan reactions and contains MgCl2, dNTPs, and AccuFast Taq 
DNA Polymerase. Amplification reactions were carried out using the ABI StepOne 
Plus machine and software (Quanta Biosciences, Gatithersburg, MD) with initial 
holding stage (95˚C for 30 seconds) and 50 cycles of a 2-step PCR (95˚C for 30 
seconds, 60˚C for 20 seconds). Fluorescent intensity of each sample was 
measured at each cycle to monitor amplification of the target gene. The 
comparative CT method was used to determine fold changes in mRNA expression 
compared to an endogenous reference gene (B-actin). This method determines 
the amount of target gene, normalized to an endogenous reference and relative to 
a calibrator (2ΔΔCT). 
G. Statistical Analyses 
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Results are reported as means ± standard error (SEM; n = 3-6). ANOVA with 
Bonferroni’s post-hoc test (for parametric data) or Mann-Whitney Rank Sum test 
(for non-parametric data) was used for the determination of statistical significance 
among treatment groups, as appropriate. A p value less than 0.05 was selected 







Over the course of the six weeks of dietary exposure, ethanol-fed mice gained 
3.2±0.4 g and pairfed mice gained 4.2±0.4 g. Ethanol feeding alone caused 
elevated plasma transaminase (ALT and AST), as did four hours of LPS exposure; 
however, these changes were not significant. Ethanol feeding significantly 
enhanced ALT levels 4 hours after LPS injection when compared with pairfed 
animals. AST levels were significantly elevated 24 hours after LPS injection in 
pairfed and ethanol-fed animals. These results are summarized in Table 1.  
1. Ethanol enhanced pulmonary damage caused by systemic administration 
of LPS. 
As expected, LPS administration caused pulmonary damage in the form of 
alveolar hemorrhage and thickening of the alveolar septa (21). Hemorrhage 
was seen as early as four hours after LPS as an increase in the number of red 
blood cells in the pulmonary intersitium (Figure 2, middle panels). Hemorrhage 
was macro-heterogeneous, with some areas of the pulmonary tissue 
experiencing more severe hemorrhage than others. Scoring of blinded 
photomicrographs (as described in Materials and Methods) revealed that 
alcohol exposure had no significant effect on the amount or severity of alveolar 
hemorrhage (Figure 3A). Significant thickening of the alveolar septa occurred 






Table 1: Routine parameters and clinical chemistry 
Data are presented as mean±SEM.  a, p < 0.05 compared to pairfed controls; 










Pairfed 25.8±0.5 4.2±0.4 N/A 22±3 32±3 
  + LPS (4h)    45±2 70±7 
  + LPS (24h)    153±57  155±30a 
EtOH 26.2±0.6 3.2±0.4 0.454±0.004 47±3   51±15 
  + LPS (4h)       99±19b   95±16 




panels). Twenty-four hours after LPS injection, alveolar walls resembled that of 
control animals in pairfed animals (Figure 2, bottom left panel); conversely, 
alveolar walls in ethanol fed animals doubled in thickness at this time point 
(Figure 2, bottom left panel). Measurements of alveolar septa in blinded 
photomicrographs reveal that these differences are statistically significant 
(Figure 3B).  
2. Ethanol did not affect recruitment of neutrophils or macrophages to the 
lung after LPS injection. 
Because ALI is associated with robust neutrophil infiltration into the 
pulmonary interstitium (43), the effects of alcohol on pulmonary neutrophil 
recruitment were assessed histologically and enzymatically. As expected, LPS 
injection caused a robust increase in the number of neutrophils in the 
pulmonary vasculature and interstitium, as indicated by an increase in the 
number of pink CAE-positive cells (Figure 4, left panel). This histological 
observation was associated with an increase in MPO activity (Figure 5A). 
Ethanol feeding did not significantly affect neutrophil recruitment compared to 
pairfed counterparts.  
Resident macrophages in many tissues, including in the lung, are often 
involved in inflammatory tissue damage. To determine if alcohol-enhanced 
pulmonary damage was caused by an increase in the number of alveolar 
macrophages, the number of alveolar macrophages was determined using 








Figure 2: Effects of chronic alcohol on pulmonary injury after LPS 
injection.  
Representative photomicrographs of lung tissue after hematoxylin and eosin 




























Figure 3: Effects of chronic alcohol feeding on indices of pulmonary 
damage. 
Alveolar hemorrhage (A) was scored in blinded H&E-stained photomicrographs 
and septal thickness (B) was measured as described in Materials and Methods. 
Indices are reported as mean ± SEM. a, p < 0.05 compared to pairfed controls; 















































































Histologically, LPS injection appeared to cause an increase in the number of 
F4/80-positive cells (Figure 4, right panel). Ethanol feeding did not have a 
significant effect on the number of F4/80 cells compared to LPS alone. This 
increase in F4/80-positive cells seen with LPS did not, however, correlate with 
an increase in F4/80 mRNA expression (Figure 5B).  
3. Alcohol exposure enhances expression of a subset of pro-inflammatory 
mediators. 
Acute lung injury is characterized by increased expression of several 
inflammatory mediators (17, 21). The effect of chronic alcohol feeding on the 
pulmonary inflammatory expression profile was determined using qRT-PCR 
(as described in Materials and Methods). Ethanol alone had no significant effect 
on expression of any inflammatory mediators measured, including TNFα, IL-6, 
IL-1β, or PAI-1 (Figure 6A). LPS injection significantly induced expression of 
these four mediators. Ethanol feeding significantly enhanced expression of the 
inflammatory cytokine IL-6. Expression of TNFα, IL-1β, and PAI-1 after LPS did 
not significantly change in animals exposed to chronic ethanol.  
Because chemokines and subsequent neutrophil recruitment are known to 
play a key role in ALI (44), the expression of several chemokines were also 
determined (Figure 6B). Once again, ethanol feeding alone did not significantly 
alter expression of any of the chemokines measured, including MCP-1, MIP-
1β, lungkine, MIP-2, and KC. LPS significantly induced expression of MCP-1, 
MIP-1β, MIP-2, and KC and significantly decreased lungkine expression. 






Figure 4: Effect of chronic alcohol feeding on pulmonary infiltration of 
neutrophils and macrophages.  
Representative photomicrographs of paraffin-embedded lung tissue samples 
stained for CAE (left) and F4/80 (right) as described in Materials and Methods 





























Figure 5: Effect of chronic alcohol feeding on myeloperoxidase (MPO) 
activity and F4/80 mRNA expression.  
MPO activity (A) and F4/80 mRNA expression (B) were determined as 
described in Materials and Methods. Data are reported as mean ± SEM. a, p < 


























































































Lungkine after LPS. In contrast, alcohol feeding significantly enhanced 
expression of MIP-2 and KC after LPS. 
Finally, expression of several adhesion molecules involved in leukocyte 
migration were measured, including ICAM-1, VCAM-1 and PECAM (Figure 
6C). In a similar pattern to other inflammatory mediators measured, alcohol 
feeding alone had no significant effect on expression of adhesion molecules. 
LPS injection alone significantly increased expression of ICAM-1 and VCAM-
1, but significantly decreased expression of PECAM. Ethanol feeding 
significantly enhanced expression of ICAM-1 and VCAM-1, but did not affect 
PECAM expression after LPS.  
4. Ethanol feeding enhanced oxidative stress after LPS injection. 
Others have shown that alcohol feeding causes glutathione depletion and 
oxidative stress in the lung (16). To determine the effect of chronic alcohol on 
oxidative stress in this model, lung tissues were stained 
immunohistochemically for the oxidative stress marker, 4-hydroxynonenol (4-
HNE; Figure 7). As demonstrated by an increase in the amount of positive 
brown staining, ethanol feeding alone caused increased oxidative stress. LPS 
injection alone caused a similar increase in 4-HNE staining. Ethanol feeding 
increased both the amount and intensity of 4-HNE staining after LPS injection. 
5. PAI-1 deficient animals are protected against alcohol-enhanced lung 
injury. 
To determine the involvement of PAI-1 in this model of alcohol-enhanced 






Figure 6: Effect of chronic alcohol feeding on LPS-induced expression of 
inflammatory mediators 
The effects of alcohol feeding on expression of inflammatory mediators (A), 
chemokines (B), and adhesion molecules (C) were measured as described in 
Materials and Methods. Data are reported as mean ± SEM. a, p < 0.05 
compared to pairfed controls; b, p < 0.05 compared to LPS alone. 
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Figure 7: Effects of chronic alcohol feeding on oxidative stress after LPS 
injection (4 h). 
Oxidative stress was assessed immunohistochemically in paraffin-embedded 
lung tissues using an antibody against the marker 4-HNE, as described in 




diet for 6 weeks (as described in Materials and Methods). Ethanol-fed control 
PAI-1-/- animals showed no significant differences in alveolar septal thickness 
compared with ethanol-fed wild-type animals or pairfed wild-type animals. As 
previously demonstrated, chronic alcohol feeding cause significant septal 
thickening 24 hours after LPS administration. On the other hand, this septal 
thickening was significantly attenuated in PAI-1 knockout animals (Figures 8A 
and 8B). Additionally, as demonstrated previously, chronic alcohol feeding 
enhanced expression of the chemokines MIP-2 and KC, and the inflammatory 
cytokine IL-6. Enhanced IL-6 expression was blunted, albeit not significantly, in 
PAI-1 knockout animals. Ethanol-enhanced MIP-2 and KC expression were 








Figure 8: Effect of PAI-1 deletion on indices of alcohol-enhanced ALI 
Representative photomicrographs of H&E-stained lung tissue sections (400X, 
A), expression of inflammatory mediators measured by qRT-PCR (B), 
quantification of septal thickening (as described in Materials and Methods) (C). 
a, p < 0.05 compared to pairfed controls; b, p < 0.05 compared to LPS alone; c, 
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Although chronic alcohol abuse does directly cause overt lung pathology, 
alcohol is known to increase susceptibility to severe lung injury, such as acute 
respiratory distress syndrome (ARDS) (7, 8).Therefore, the primary goal of this 
work was to characterize the effects of chronic alcohol exposure on inflammation 
and injury in a mouse model of acute lung injury in experimental endotoxemia 
utilizing systemically administered LPS. In accordance with previous studies (16, 
21), experimental endotoxemia caused pulmonary injury, as evidenced by alveolar 
hemorrhage and septal thickening indicative of pulmonary edema. Chronic ethanol 
exposure did not affect the presence or severity of alveolar hemorrhage, but 
chronic ethanol did enhance and prolong septal thickening. These data are similar 
to findings by Holguin and colleagues, who determined that ethanol enhanced 
edematous lung injury in a rat model of ethanol pre-exposure and experimental 
endotoxemia (16). These data suggest that chronic alcohol exposure sensitizes 
the lung parenchyma to enhanced inflammatory damage. 
 In this model, chronic alcohol feeding had specific effects on the pulmonary 
inflammatory response after LPS. Alcohol alone did not cause a generalized 
increase in expression of pro-inflammatory mediators; instead, alcohol enhanced 
LPS-induced expression of a specific set of inflammatory mediators, including 
cytokines, chemokines, and adhesion molecules. One of these mediators was the 
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cytokine, IL-6. IL-6 is a pleotropic cytokine that is widely accepted to be involved 
in the acute phase response (45). Interestingly, IL-6 has been shown to have both 
pro- and anti-inflammatory properties (45). In fact, expression of adhesion 
molecules, including ICAM-1 and VCAM-1 has been demonstrated to be induced 
by IL-6 signaling, leading to enhanced neutrophil infiltration into target tissues (45, 
46). Moreover, STAT3, which is activated by IL-6 has been shown to be critically 
involved in acute lung inflammation in a model of Streptococcus infection (47). 
Inhibition of STAT3 caused a dramatic decrease in M1-protein induced pulmonary 
edema, MPO activity, and CXC chemokine production.   
On the other hand, IL-6 is an important cytokine in the resolution of 
inflammation.  IL-6 is also known to be involved in the transition from the innate to 
the adaptive immune response, particularly the switch away from neutrophil 
recruitment to monocyte recruitment (48). Moreover, IL-6 drives differentiation of 
monocytes to macrophages. Others have shown that IL-6 knockout mice have 
enhanced pulmonary neutrophil recruitment, MIP-2 expression, TNF-α expression, 
and mortality in a model of LPS-induced acute lung injury (49). This thesis 
demonstrated that alcohol feeding drastically enhanced IL-6 expression after 
systemic LPS administration.  This enhanced expression may be involved in 
increased neutrophil chemotaxis through the upregulation of the adhesion 
molecules ICAM and VCAM, as well as through the STAT3-mediated production 
of the CXC chemokines MIP-2 and KC. Conversely, enhanced IL-6 expression 
may be a compensatory mechanism involved in the resolution of alcohol-enhanced 
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inflammation. These opposing effects make IL-6 an interesting target for future 
study in this model of alcohol-enhanced ALI.  
A hallmark of ARDS is a robust increase in the expression of the potent 
neutrophil chemoattractant, IL-8 (20). IL-8 has a well-defined role in ALI and ARDS 
through the recruitment and activation of neutrophils, and increased levels of IL-8 
in the BALF of patients has been associated with an increased risk of developing 
ARDS, as well as increased mortality (44). In this model of alcohol-enhanced acute 
lung injury, chronic alcohol consumption enhanced expression of the murine IL-8 
homologues, MIP-2 and KC. Although chronic alcohol robustly enhanced MIP-2 
and KC expression caused by LPS, there was not an associated increase in 
recruitment of inflammatory cells, including macrophages and neutrophils.  This 
suggests that while the number of neutrophils is unchanged, neutrophils in alcohol-
fed animals may show increased activation, and therefore, increased tissue 
damage.  
In fact, a marker of neutrophil activation is the generation of reactive oxygen 
species (ROS) for the killing and phagocytosis of pathogens- a phenomenon 
known as oxidative burst (50). Others have shown that IL-8 stimulation primes 
neutrophils for oxidative burst in a dose-dependent manner (51), suggesting that 
enhanced MIP-2 and KC expression (IL-8 homologues) may contribute to 
enhanced pulmonary damage due to neutrophil-mediated oxidative stress. Indeed, 
this work has demonstrated that chronic alcohol feeding causes enhanced 
oxidative stress after LPS administration. Additionally, others have demonstrated 
that oxidative stress itself can enhance IL-8 production (52). Previous work has 
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demonstrated that alcohol administration causes oxidative stress in the lung via 
glutathione depletion (16). The work presented in this thesis has confirmed this 
finding in a murine model. These results suggest that alcohol, via the induction of 
oxidative stress, primes macrophages to enhanced chemokine production after an 
inflammatory stimulus, such as LPS. This enhanced IL-8 production (or MIP-2/KC 
in rodents) may enhance the oxidative burst of recruited neutrophils, leading to 
enhanced inflammatory damage of pulmonary tissues. This hypothesis is outlined 
in Figure 9.  
Finally, the current work has identified a potential novel role of PAI-1 in alcohol-
enhanced ALI. As mentioned previously, the Arteel group has identified a critical 
role of PAI-1 in the development of alcohol-induced liver injury and inflammation 
(26, 27). Indeed, PAI-1 knockout mice were protected against alcohol-induced liver 
injury, inflammation, and necrosis in an enteral model of chronic alcohol exposure 
(26). As mentioned previously, PAI-1 is also known to play a role in several models 
of experimental ALI (33, 34, 37). Interestingly, in the model of alcohol-enhanced 
ALI described here, PAI-1 expression was not significantly enhanced after LPS by 
alcohol feeding, yet PAI-1 knockout animals were protected against enhanced 
septal thickening and chemokine production. These results suggest that while PAI-
1 itself may not be directly involved, it is involved in critical pathways in the 
development of alcohol-enhanced ALI. This makes PAI-1 a unique target for 






















SUMMARY AND CONCLUSIONS 
Strengths of this work 
This thesis has many strengths. First, it establishes and characterizes a 
murine model of alcohol-enhanced ALI. Patients meeting the diagnostic criteria for 
an alcohol use disorder are 3.7 times more likely to develop acute respiratory 
distress syndrome (7, 8), suggesting that chronic alcohol sensitizes the lung to 
injury. The effects of chronic alcohol exposure on the development of lung injury 
have been investigated in other species (23), as well as in other models of alcohol 
administration (e.g. in drinking water). The characterization of the mouse model 
described in this work is particularly useful, however, because of the wide variety 
of genetically modified strains readily available at relatively low cost compared to 
other animal models.  
Secondly, this work utilizes an in-vivo approach which accounts for the 
interaction of many pathways and organ systems. In particular, alcohol-induced 
organ pathology is complex, involving interactions between multiple organ 
systems, including the gut and the liver.  Systemically administered LPS is a 
common model used to study ALI resulting from a systemic infection, and the 
model used for these studies is considered particularly relevant because of its 
ability to mimic sepsis-induced ALI (18). Intratracheal administration of LPS 
induces a robust inflammatory response, but confounding factors, such as 




Additionally, these studies identified potential mechanisms by which alcohol 
sensitizes the lung to injury and reveal potential targets for therapy for alcoholic 
patients at risk for developing ARDS. Others have shown that alcohol 
administration causes pulmonary glutathione depletion and oxidative stress (16, 
23, 53). It is also known that oxidative stress enhances expression of IL-8 from 
dendritic cells (52), which may then prime neutrophils to enhanced production of 
reactive oxygen species (ROS). Indeed, this work demonstrates that chronic 
alcohol exposure enhanced pulmonary oxidative stress after LPS administration. 
Furthermore, enhanced oxidative stress caused by ethanol pre-exposure was 
associated with enhanced alveolar septal thickening, a sign of tissue damage. 
Other studies have shown that N-acetylcysteine (NAC), a glutathione precursor, is 
protective in models of acute alcohol-induced liver injury (54). The lung is 
dependent on liver-derived glutathione (23), and alcohol intoxication depletes 
hepatic glutathione. Additionally, NAC has been shown to be protective in a model 
of LPS-induced ALI (55). Pretreatment with NAC has been shown to protect 
against hepatic glutathione depletion in mouse models (54), and may therefore 
protect the lung during alcohol-enhanced ALI. NAC has been used in clinical trials 
in alcoholic hepatitis in combination with other drugs with some effectiveness (56), 
and has improved intracellular glutathione pools and patient outcome in ARDS 
patients (57). Thus, it is possible that N-acetylcysteine could also protect the lung 





Finally, this work has identified a novel role of PAI-1 in mediating the 
sensitizing effects of alcohol in the setting of acute lung injury. While PAI-1 is 
known to play a role in other models of acute lung injury (33, 34, 37), its role in 
alcohol-enhanced ALI has not been investigated. While the exact mechanism by 
which PAI-1 is involved in alcohol-enhanced ALI remains unclear, this study 
demonstrates that PAI-1 is critically involved in alcohol-enhanced chemokine 
production and inflammatory damage (e.g. alveolar septal thickening). These 
results introduce an interesting, novel target for future investigation.  
Unanswered questions and future directions 
What is the role of PAI-1 in alcohol-enhanced ALI? 
The Arteel group has previously identified a critical role of PAI-1 in alcohol-
induced liver injury and inflammation (26). Specifically, knocking out PAI-1 
produced potent anti-inflammatory effects in a chronic enteral alcohol model (25). 
Classically, PAI-1 is an inhibitor of tissue-type plasminogen activator and 
urokinase-type plasminogen activator (tPA and uPA, respectively), thereby 
preventing the conversion of plasminogen to plasmin. Plasmin is involved in the 
coagulation cascade by degrading the extracellular matrix protein fibrin. Therefore, 
PAI-1 plays a major role in regulating fibrinolysis. The Arteel group has also 
demonstrated the critical role of PAI-1-induced fibrin accumulation in alcohol-
induced liver injury (27). Ethanol pre-exposure enhanced LPS-induced fibrin 
deposition in the hepatic sinusoidal space, and inhibiting fibrin deposition protected 
against enhanced liver injury and inflammation. 
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  The work described in this thesis has identified PAI-1 as a key mediator in 
alcohol-enhanced lung injury and chemokine production, despite the fact that PAI-
1 induction is not significantly enhanced by alcohol feeding. Future experiments 
should determine the role of PAI-1 in alcohol-enhanced ALI, particularly the role of 
PAI-1-mediated fibrin accumulation. 
What is the role of ECM remodeling in alcohol-enhanced ALI? 
One mechanism by which PAI-1 may contribute to alcohol-enhanced ALI is 
by mediating ECM remodeling. In addition to its role in fibrinolysis, PAI-1 indirectly 
regulates the expression of many other ECM proteins, including laminin, 
proteoglycan, and type IV collagen via inhibition of matrix metalloproteinases 
(MMPs) (58-61) (62). PAI-1 induction has also  been shown to enhance fibronectin 
ECM deposition (63). Many cell types, including alveolar macrophages, bind to 
select ECM proteins under basal conditions, and cell surface receptors known as 
integrins mediate crosstalk between the ECM and the cell (64). For example, fibrin 
interacts with RGD-binding integrins, including integrin αVβ3. Previous work from 
the Arteel group has demonstrated that blocking fibrin-integrin interactions protects 
against alcohol-induced liver injury with no effect on fibrin accumulation (65), 
suggesting that integrin αVβ3 signaling is critical for the progression of liver injury. 
Alveolar macrophages bind with high affinity to fibronectin and vitronectin ECM via 
the integrins α5β1 and αVβ3, respectively. Chronic alcohol exposure has been 
shown to cause deposition of a fibronectin-enriched pulmonary ECM. PAI-1 
induction can inhibit vitronectin-integrin interactions, impairing tissue repair (66). 
Thus, changing the ECM substratum can alter integrin signaling, and subsequently 
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the phenotype of the surrounding cells. For example, ligation of the integrin αVβ3 
has been shown to enhance expression of pro-inflammatory cytokines via NFκB 
activation (67), and α5β1-mediated macrophage binding to fibronectin can also be 
pro-inflammatory (62). Future research will examine the role of PAI-1-mediated 
ECM alterations, and how this altered ECM profile may affect integrin signaling, 
and therefore, the inflammatory response.  
Is the liver involved in alcohol-enhanced lung injury? 
A recent focus of the Arteel group has been to investigate parallel, and 
potentially interdependent mechanisms of liver and lung injury in the setting of 
chronic alcohol exposure. For example, the current work has identified PAI-1 
activity as a potential parallel mechanism of organ injury. Additionally, the work 
presented here, and additional work from the Arteel group suggests that liver-
derived mediators (e.g. TNFα (68)) may be directly involved in alcohol-enhanced 
lung inflammation. For example, the Arteel group has recently found that 
administration of the TNFα-blocking drug, etanercept, prevented alcohol-
enhanced induction of MIP-2 and KC after LPS administration (Massey et. al., 
under review).  Additionally, Siore and collaborators demonstrated a possible 
interaction between the liver and lung in an in situ perfused piglet preparation (69).  
This model revealed that hypoxemia and pulmonary edema were only observed 
when the liver and lung circulations were connected.  Their results indicate that 
while endotoxemia could directly cause pulmonary vasoconstriction and leukocyte 
sequestration, interaction between the liver and lung was required for severe 
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inflammatory response and oxidative injury to the lung.  Future research should 
elucidate and solidify this potential link between the liver and the lung.  
Lastly, PAI-1 is a known downstream target of TNFα signaling. Future 
research should investigate the role of hepatic-derived TNFα in the induction and 
activity of PAI-1 in this model of alcohol-enhanced ALI.  
Conclusions 
In conclusion, this thesis has established and characterized a mouse model 
of alcohol-enhanced acute lung injury. It was determined that alcohol enhances 
LPS-induced alveolar septal thickening, as well as LPS-induced pulmonary 
expression of IL-6 and the murine IL-8 homologues MIP-2 and KC. These effects 
were potentially mediated by oxidative stress. This thesis also identified PAI-1 as 
a novel mediator of alcohol-enhanced pulmonary injury. This thesis is of interest 
because it establishes a mouse model which can be used in future studies to 
elucidate the mechanisms by which alcohol consumption sensitizes the lung to 
further injury. Although this thesis has characterized many aspects of ALI, ALI is a 
complicated disease state, and no single animal model is able to recapitulate all 
clinical aspects of the disease. However, this model has proven useful for the study 
of edematous injury and cytokine/chemokine production – two highly relevant 
clinical markers of ARDS. This model will be useful in future studies, including 
investigation of the role of PAI-1 and PAI-1-mediated ECM remodeling in alcohol-
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ALI Acute lung injury 
ALT Alanine transaminase  
ARDS Acute respiratory distress syndrome 
AST Aspartate transaminase 
BAL Bronchoalveolar lavage 
BALF Bronchoalveolar lavage fluid 
CAE Chloroacetate esterase 
DAB 3, 3’-diaminobenzidine 
EtOH Ethanol 
H&E Hematoxylin and eosin 
HTAB Hexadecyltrimethylammonium bromide 
ICAM-1 Intracellular adhesion molecule 1 
IL-1β Interleukin 1 beta 
IL-6 Interleukin 6 
IL-8 Interleukin 8 
I.P. Intraperitoneal  
KC Keratinocyte-derived chemokine 
KO Knockout  
LPS Lipopolysaccharide  
MCP-1 Monocyte chemoattractant protein 1 
MIP-1β Macrophage inflammatory protein 1 beta 
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MIP-2 Macrophage inflammatory protein 2 
MPO Myeloperoxidase  
PAI-1 Plasminogen activator inhibitor one 
PECAM Platelet endothelial cell adhesion molecule 
qRT-PCR Quantitative reverse-transcription polymerase chain reaction 
ROS Reactive oxygen species 
STAT3 Signal transducers and activators of transcription 3 
TNFα Tumor necrosis factor alpha 
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